Nasdaq · CIK 0001847345
ASBP Aspire Biopharma Holdings, Inc.
Insider trading from SEC Form 4. Last filing Jun 10, 2025. Close $8.30 on Oct 9, 2026, +5255% from the 52-week low and -53% from the high.
In brief
Aspire Biopharma Holdings, Inc. (ASBP) has 2 SEC Form 4 filings on file from 1 insider, the latest filed on Jun 10, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at ASBP. The newest: Donald G. Fell (director) bought $7,800 of stock on Jun 4, 2025, filed Jun 10, 2025, scored 31 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Aspire Biopharma Holdings, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Donald G. Fell director buy | $7,800 20,000 shares | - | +74% from low-97% from high | |
| 31Weak | Donald G. Fell director buy | $7,800 20,000 shares | - | +74% from low-97% from high |
Transactions
Every row filed, 4 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | Donald G. Fell director | POpen-market purchase Common Stock, par value $0.0001 | +9,500 | $0.39 | $3,705 | 9,500 | Jun 10, 2025 |
| Jun 5, 2025 | Donald G. Fell director | POpen-market purchase Common Stock, par value $0.0001 | +10,500 | $0.39 | $4,095 | 20,000 | Jun 10, 2025 |
| Jun 4, 2025 | Donald G. Fell director | POpen-market purchase Common Stock, par value $0.0001 | -9,500 | $0.39 | $3,705 | 9,500 | Jun 6, 2025 |
| Jun 5, 2025 | Donald G. Fell director | POpen-market purchase Common Stock, par value $0.0001 | -10,500 | $0.39 | $4,095 | 20,000 | Jun 6, 2025 |
Questions about ASBP
Answered from the filings on this page, as of the latest one.
Are insiders buying ASBP?
No. In the last 90 days no insider at Aspire Biopharma Holdings, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ASBP on the open market?
Donald G. Fell (director) bought $7,800 of ASBP on Jun 4, 2025 and filed the Form 4 on Jun 10, 2025. InsiderTell scored 31 (weak).
How many insiders file Form 4 at Aspire Biopharma Holdings, Inc.?
1 person has filed a Form 4 at Aspire Biopharma Holdings, Inc., among them Donald G. Fell (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.